As fiscal year-end approaches for many organizations, multinational enterprises (MNEs) need to evaluate whether their transfer pricing arrangements continue to produce arm's length prices and allocations. This is particularly true this year considering the economic impact of the coronavirus (COVID-19) pandemic. MNEs thus need to consider potential transfer pricing planning opportunities that may help alleviate financial stress caused by the pandemic.
It is always a best practice for MNEs to confirm at year-end that the transfer pricing policy for a controlled transaction has been adhered to, such as to evaluate whether the targeted distribution margin for a limited risk distributor continues to be consistent with the margins realized by comparable distributors. However, given the economic impact of COVID-19, there are additional economic factors that MNEs need to consider even when the historical transfer pricing method continues to be consistent with arm's length terms and conditions, including:
There may also be situations when a company's response to the COVID-19 pandemic either necessitates a change or presents an opportunity to revisit a historical transfer pricing method or policy in the following areas:
Before fiscal year-end, MNEs may also want to consider other issues related to:
Read a November 2020 report prepared by the KPMG member firm in Canada
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.